Bicara Therapeutics Statistics

Total Valuation

BCAX has a market cap or net worth of $618.20 million. The enterprise value is $183.83 million.

Market Cap	618.20M
Enterprise Value	183.83M

Important Dates

The last earnings date was Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BCAX has 54.56 million shares outstanding. The number of shares has increased by 6,191.81% in one year.

Current Share Class	54.56M
Shares Outstanding	54.56M
Shares Change (YoY)	+6,191.81%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	2.25%
Owned by Institutions (%)	59.86%
Float	26.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.42
P/TBV Ratio	1.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.80, with a Debt / Equity ratio of 0.01.

Current Ratio	25.80
Quick Ratio	25.34
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.71% and return on invested capital (ROIC) is -24.00%.

Return on Equity (ROE)	-32.71%
Return on Assets (ROA)	-22.85%
Return on Invested Capital (ROIC)	-24.00%
Return on Capital Employed (ROCE)	-27.75%
Revenue Per Employee	n/a
Profits Per Employee	-$1.87M
Employee Count	55
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BCAX has paid $310,000 in taxes.

Income Tax	310,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	10.50
200-Day Moving Average	14.12
Relative Strength Index (RSI)	55.49
Average Volume (20 Days)	308,532

Short Selling Information

The latest short interest is 5.59 million, so 10.24% of the outstanding shares have been sold short.

Short Interest	5.59M
Short Previous Month	5.64M
Short % of Shares Out	10.24%
Short % of Float	21.22%
Short Ratio (days to cover)	14.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-121.07M
Pretax Income	-64.84M
Net Income	-102.67M
EBITDA	-121.00M
EBIT	-121.07M
Earnings Per Share (EPS)	-$2.35

Full Income Statement

Balance Sheet

The company has $436.61 million in cash and $2.24 million in debt, giving a net cash position of $434.37 million or $7.96 per share.

Cash & Cash Equivalents	436.61M
Total Debt	2.24M
Net Cash	434.37M
Net Cash Per Share	$7.96
Equity (Book Value)	435.20M
Book Value Per Share	7.98
Working Capital	427.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$100.96 million and capital expenditures -$48,000, giving a free cash flow of -$101.00 million.

Operating Cash Flow	-100.96M
Capital Expenditures	-48,000
Free Cash Flow	-101.00M
FCF Per Share	-$1.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6,191.81%
Shareholder Yield	-6,191.81%
Earnings Yield	-16.61%
FCF Yield	-16.34%

Analyst Forecast

The average price target for BCAX is $29.17, which is 157.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$29.17
Price Target Difference	157.69%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2